Follow
Venu Yakati
Venu Yakati
Postdoctoral Research Associate at the University of Alabama
Verified email at ua.edu
Title
Cited by
Cited by
Year
Amphetamine decorated cationic lipid nanoparticles cross the blood–brain barrier: therapeutic promise for combating glioblastoma
S Saha, V Yakati, G Shankar, MMCS Jaggarapu, G Moku, ...
Journal of Materials Chemistry B 8 (19), 4318-4330, 2020
382020
In vivo Targeting of DNA Vaccines to Dendritic Cells via the Mannose Receptor Induces Long‐Lasting Immunity against Melanoma
G Moku, S Vangala, SK Gulla, V Yakati
ChemBioChem 22 (3), 523-531, 2021
282021
Systemic codelivery of a homoserine derived ceramide analogue and curcumin to tumor vasculature inhibits mouse tumor growth
S Barui, S Saha, V Yakati, A Chaudhuri
Molecular Pharmaceutics 13 (2), 404-419, 2016
222016
Combating Established Mouse Glioblastoma through Nicotinylated‐Liposomes‐Mediated Targeted Chemotherapy in Combination with Dendritic‐Cell‐Based Genetic Immunization
S Saha, Y Venu, D Bhattacharya, SD Kompella, K Madhusudana, ...
Advanced biosystems 1 (1-2), 1600009, 2017
162017
Enhancing the anticancer effect of paclitaxel by using polymeric nanoparticles decorated with colorectal cancer targeting CPKSNNGVC-peptide
V Yakati, S Vangala, VS Madamsetty, R Banerjee, G Moku
Journal of Drug Delivery Science and Technology 68, 103125, 2022
102022
Glucocorticoid receptor-targeted liposomal delivery system for delivering small molecule ESC8 and anti-miR-Hsp90 gene construct to combat colon cancer
S Jinka, HK Rachamalla, T Bhattacharyya, K Sridharan, ...
Biomedical Materials 16 (2), 024105, 2021
92021
Enriched pharmacokinetic behavior and antitumor efficacy of thymoquinone by liposomal delivery
HK Rachamalla, S Bhattacharya, A Ahmad, K Sridharan, VS Madamsetty, ...
Nanomedicine 16 (8), 641-656, 2021
62021
In vivo targeting of a tumor-antigen encoded DNA vaccine to dendritic cells in combination with tumor-selective chemotherapy eradicates established mouse melanoma
S Barui, S Saha, Y Venu, GK Moku, A Chaudhuri
Biomaterials Science 11 (18), 6135-6148, 2023
12023
Novel Suberoylanilide Hydroxamic Acid Analogs Inhibit Angiogenesis and Induce Apoptosis in Breast Cancer Cells
G Moku, S Vangala, V Yakati, CC Gali, S Saha, VS Madamsetty, A Vyas
Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal …, 2022
12022
Glioblastoma mechanobiology at multiple length scales
RV Kondapaneni, SK Gurung, PS Nakod, K Goodarzi, V Yakati, NA Lenart, ...
Biomaterials Advances, 213860, 2024
2024
Magnetic Quantum Dots for In-Vivo Imaging
V Yakati, S Vangala, VJ Reddy, B Gidwani, A Vyas, V Jain, V Joshi, ...
Magnetic Quantum Dots for Bioimaging, 227-240, 2023
2023
Surface Modified Glucose-Derived, Blood Brain Barrier-Crossing Nanospheres Dually Targets Macrophage and Cancer Cells for Effective In Situ Anti-Glioma Effect
M Jaggarapu, A Ansari, S Jinka, K Sridharan, N Nimmu, NS Mahadik, ...
Blood Brain Barrier-Crossing Nanospheres Dually Targets Macrophage and …, 0
Liposomal drug carriers for selective targeting of cancer therapeutics to glioblastoma and colorectal cancer
V Yakati
Ghaziabad, 0
The Immunomodulatory Effects on Tumor-Associated Macrophages by Integrin Receptor-Targeted Delivery of Doxorubicin-Loaded Cerium Oxide Nanoparticles to Combat Glioblastoma
G Koula, V Yakati, HK Rachamalla, K Bhamidipati, M Kathirvel, ...
Available at SSRN 4500354, 0
The system can't perform the operation now. Try again later.
Articles 1–14